COVID-19 and microvascular thrombosis/inflammation effects
During the ICTHIC webinar “Clinical insights in CAT to include COVID‐19“, Dr. Vincent Labbé gave a talk on...
AUTHORS
ICTHIC Editorial Office
ICTHIC Editorial Office is based in Milan, Italy, c/o Polistudium srl.
Sara di Nunzio, Italy, Managing Editor
Aashni Shah, UK, Editor
Francesca Cappellini, Italy, Medical Writer and Social Media Manager
Massimiliano Pianta, Italy, Graphic Designer
Giorgio Maitti, IT Developer
Phone +39 3714686513
email: editorialoffice@magazine.icthic.com
Sara di Nunzio, Italy, Managing Editor
Aashni Shah, UK, Editor
Francesca Cappellini, Italy, Medical Writer and Social Media Manager
Massimiliano Pianta, Italy, Graphic Designer
Giorgio Maitti, IT Developer
Phone +39 3714686513
email: editorialoffice@magazine.icthic.com
Multiple myeloma-associated VTE risk prediction. A talk report from the 10th ICTHIC
During the 10th ICTHIC, prof Kristen Sanfilippo (Assistant Professor at the Washington University School of Medicine in...
The TESEO registry and how it can help patients with CAT
Cancer-associated thrombosis management is incredibly challenging because of the high risk of recurrence and severe...
VTE in Palliative Care Patients: What do we know? A talk report from the 10th ICTHC
During the 10th ICTHIC, Professor Simon Noble (Cardiff University, UK) talked about the management of VTE in patients...
Venous thromboembolism risk and immune checkpoint inhibitors: what the literature says.
Patients with cancer have an increased risk of venous and arterial thromboembolism (VTE/ATE) . Several factors have...
Inpatient thromboprophylaxis in cancer patients: what is the evidence? A talk report from the 10th ICTHIC
During the 10th ICTHIC, Prof. Jeffrey Zwicker (Harvard Medical School, MA, USA) gave an overview of the evidence of the...
Tools to raise thrombosis awareness in patients with cancer: a lesson from the EMPOWER study
Cancer-associated thrombosis (CAT) is the most frequent cause of death in patients with cancer after cancer itself . In...
VTE risk in patients with lung cancer
Lung cancer is associated with a very high risk of developing venous thromboembolism (VTE). In a large...
Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia and preliminary data from the MATTER study: A talk report from the 10th ICTHIC conference
During the 10th ICTHIC, Dr. Avi Leader (hematologist at Rabin Medical Center in Petah Tikva, Israel) talked about...
Cancer-associated thrombosis: mechanisms and risk factors
Blood clot generation in people with cancer follows a process distinct from the non-cancer population. Cancer tissue is...